Latest KVUE news

Kimberly-Clark offers remedies in bid for EU approval of Kenvue deal

Reuters · Wed, 23 Sep 2026 05:34:45 -0400

Kimberly-Clark has offered concessions to address EU antitrust concerns about its $40 billion bid for Tylenol maker Kenvue , a filing ‌on the European Commission website showed on Wednesday.

5 Beaten-Down Dividend Kings Ready to Roar Back in 2027 (One Yields Over 5%)

24/7 Wall Street · Tue, 22 Sep 2026 09:12:16 -0400

While investors pile into pricey AI darlings, a handful of battle-tested Dividend Kings have quietly slipped to levels that scream value, and Wall Street analysts see serious upside ahead for 2027.

Better Dividend King to Buy and Hold: Johnson & Johnson or Kenvue?

The Motley Fool · Thu, 17 Sep 2026 23:30:00 -0400

Johnson & Johnson has raised its dividend for 64 straight years, but faces billions in talc-related litigation liabilities. Kenvue offers a higher yield of 4.71%, but its pending acquisition by Kimberly-Clark creates uncertainty about its dividend outlook.

Kimberly-Clark readies EU remedies in bid for Kenvue deal, sources say

Reuters · Mon, 14 Sep 2026 06:56:41 -0400

Kimberly-Clark is readying concessions to address EU antitrust concerns about ‌its bid for Tylenol maker Kenvue that could help it win approval for the $40 billion deal after ⁠a preliminary review, people familiar with the matter said.

Kimberly-Clark's 54-Year Dividend Streak Faces Its Biggest Test Yet With $48.7 Billion Kenvue Deal

24/7 Wall Street · Sat, 12 Sep 2026 13:49:11 -0400

Kimberly-Clark just raised its dividend for the 54th straight year while simultaneously chasing a nearly $50 billion acquisition, and income investors are now weighing whether a deal of that size can coexist with a payout that costs over $1.

My Favorite Consumer Staples Play Right Now

ETF Trends · Sat, 12 Sep 2026 08:06:34 -0400

Owning consumer staples stocks is an absolute must in a dividend investing strategy. Most people turn to dividend stocks for two reasons — to generate income or to put the magic of compounding to work using dividend reinvestment to amplify wealth building over time.

Kenvue Declares Quarterly Cash Dividend

Business Wire · Thu, 10 Sep 2026 06:45:00 -0400

SUMMIT, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors declared a quarterly dividend of $0.21 per share on its common stock. The quarterly dividend is payable on October 2, 2026, to shareholders of record as of the close of business on September 21, 2026. About Kenvue Kenvue Inc. is the world's largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson.

Market information is provided for research and visualization and is not investment advice.